The oral medication is not as effective for some peopleabout a quarter of patients did not lose 5% or more of their weight, she said
The investigation specifically showed that these drugs did not increase the risk of any fractures, confirming their safety profile in clinical practice ( 4.6 Ophthalmological effects 4.6.1 Glaucoma GLP-1R agonists exhibit anti-inflammatory and neuroprotective properties, suggesting they could also be beneficial in neurodegenerative diseases ( A recent registry-based case-control study, summarized in Table 2 , involving 1,961 patients found that the use of GLP-1R agonists is linked to a lower risk of glaucoma (Sterling et al., 2021 ( Table 2 Clinical studies elucidating the use of antidiabetics against glaucoma
These reactions require immediate medical attention
Sousa JA, McKay DM, Raman M (2024) Selenium, Immunity, and Inflammatory Bowel Disease
BPC-157 .
4 The short-acting GLP-1 agonists retain relatively potent effects on gastric emptying because intermittent receptor stimulation avoids tachyphylaxis
